Amoxyking-CV 625

Amoxyking (amoxicillin/clavulanate) is a combination antibiotic used to treat a range of bacterial infections, including UTIs, sinus infections, and ear infections etc. It combines amoxicillin, which disrupts bacterial cell walls, with clavulanate potassium, a beta-lactamase inhibitor that prevents bacteria from counteracting the antibiotic. This dual action makes Augmentin effective against bacteria that might otherwise be resistant to antibiotics.

Brand Name

Amoxyking-CV625

Ingredients

Amoxycillin 500 mg + Potassium Clavulanate 125 mg

Packaging

Tablet Strip

Intended Use

Antibiotic
Connect with us
Facebook Instagram
Amoxyking (amoxicillin/clavulanate) treats bacterial infections by combining two complementary agents. Amoxicillin, a penicillin antibiotic, destroys bacteria by disrupting their protective cell walls. Clavulanate, a beta-lactamase inhibitor, blocks bacterial enzymes that would otherwise break down amoxicillin, enhancing its effectiveness. This combination allows Amoxyking to effectively target bacteria that may resist standard antibiotics.

Uses of Amoxyking - CV625

The tablet is used for the treatment of the following infections in both adults and children:
  • Infections of the lower respiratory tract
  • Urinary Tract Infections (UTIs)
  • Sinusitis
  • Skin infections like cellulitis
  • Ear infections

Possible Side Effects

Temporary side effects may include:
  • Diarrhea or loose motion
  • Nausea
  • Skin rash
  • Itching or allergic reactions
  • Upper Respiratory tract infection

Usage Instructions

To maximize the efficacy of Amoxyking (a combination of Amoxicillin and clavulanate potassium), and to minimize the potential for  gastrointestinal issues, it is recommended to administer each dose at the beginning of a meal. You should maintain a 12-hour interval between doses. This medication should be prescribed only when there is confirmed bacterial infection, as prudent use is essential in reducing antibiotic resistance and ensuring the drug’s effectiveness over time.